Altmetrics
Downloads
57
Views
39
Comments
0
A peer-reviewed article of this preprint also exists.
† These authors contributed equally to this work.
This version is not peer-reviewed
Submitted:
05 September 2024
Posted:
06 September 2024
You are already at the latest version
Source | Phase1 | Range of SID Trp: Lys ratio |
Range of SID Lys, % |
Remarks |
Kwon et al. [7] | 3 | 0.18-0.28 | 1.00 | |
Tolosa et al. [24] | 3 | 0.16-0.19 | 0.81-0.89 | |
Kerkaert et al. [25] | 3 | 0.19-0.21 | 0.98 | |
Ma et al. [26] | 1 | 0.15-0.24 | 1.10 | |
Capozzalo et al. [27] | 1 | 0.17-0.25 | 1.23-1.27 | |
Liu et al. [28] | 2-3 | 0.15-0.23 | 0.90 | |
Wensley et al. [29] | 2 | 0.16-0.21 | 1.25 | |
Gonçalves et al. [30] | 3 | 0.15-0.25 | 0.90 | |
Capozzalo et al. [31] | 1 | 0.16-0.24 | 1.25 | E. coli infection |
Jayaraman et al. [32] | 1 | 0.16-0.25 | 1.18 | E. coli infection |
Jayaraman et al. [33] | 1 | 0.19-0.24 | 1.23-1.33 | Unclean condition |
Yu et al. [34] | 3 | 0.13-0.21 | 0.66 | |
Capozzalo et al. [35] | 1 | 0.16-0.24 | 1.24 | E. coli infection |
Gonçalves et al. [36] | 1-2 | 0.15-0.25 | 0.97-1.30 | |
Nørgaard et al. [37] | 1 | 0.13-0.23 | 1.09 | |
Shen et al. [38] | 2-3 | 0.16-1.10 | 0.90-1.17 | Stress |
Naatjes et al. [39] | 2-3 | 0.13-0.21 | 1.05 | |
Borgesa et al. [40] | 1 | 0.18-0.24 | 0.92 | |
Capozzalo et al. [41] | 1 | 0.17-0.26 | 1.24 | E. coli infection |
Quant et al. [42] | 3 | 0.13-0.18 | 0.66 | |
Shen et al. [43] | 2 | 0.21-1.31 | 0.90 | |
Zhang et al. [44] | 3 | 0.13-0.25 | 0.90 | |
Le Floc’h et al. [45] | 1-3 | 0.15-0.24 | 1.05-1.22 | |
Trevisi et al. [46] | 1 | 0.18-0.22 | ND2 | E. coli infection |
Eder et al. [47] | 3 | 0.09-0.23 | 0.87 |
Source | Phase1 | Range of SID Val: Lys ratio |
Range of SID Lys, % |
Range of SID Leu: Lys ratio |
Range of SID Ile: Lys ratio |
Remarks |
Goodarzi et al. [48] | 1-2 | 0.39-0.75 | 1.29 | 0.82 | 0.29; 0.60 | BCAA interaction |
Clizer et al. [11] | 3 | 0.60-0.80 | 0.98 | 1.34 | 0.60 | |
Goodarzi et al. [8] | 1-2 | 0.39-0.75 | 1.29 | 0.81 | 0.30; 0.55 | BCAA interaction |
Habibi et al. [9] | 1-2 | 0.37-0.62 | 1.29 | 0.77 | 0.31; 0.55 | BCAA interaction |
Kerkaert et al. [25] | 3 | 0.70-0.80 | 0.98 | 1.45 | 0.61 | |
Siebert et al. [49] | 1-3 | 0.70-0.76 | 1.15-1.25 | 1.03-1.06 | 0.58 | |
Millet et al. [50] | 1-2 | 0.58-0.82 | 1.05 | 1.05 | 0.54 | |
Oliveira et al. [51] | 1 | 0.71-0.87 | 1.41-1.43 | ND2 | ND2 | |
Gonçalves et al. [52] | 3 | 0.57-0.78 | 0.85 | 1.54-1.58 | 0.61-0.62 | |
Xu et al. [53] | 1-2 | 0.50-0.80 | 1.17 | 0.99 | 0.53 | |
Zhang et al. [54] | 2-3 | 0.45-0.65 | 1.15 | ND2 | ND2 | |
Clark et al. [55] | 1-2 | 0.50-0.85 | 1.24 | 1.10 | 0.57 | |
Liu et al. [56] | 3 | 0.55-0.75 | 0.90 | 1.13 | 0.51 | |
Soumeh et al. [57] | 1-2 | 0.58-0.78 | 1.10 | ND2 | ND2 | |
Nemechek et al. [58] | 1-2 | 0.57-0.70 | 1.30 | ND2 | ND2 | |
Millet [59] | 1-2 | 0.58-0.67 | 1.06 | 0.96 | 0.52 | |
Waguespack et al. [60] | 2-3 | 0.61-0.74 | 0.83 | 1.30 | 0.60 | |
Gaines et al. [61] | 2-3 | 0.55-0.80 | 1.10 | ND2 | ND2 | |
Gloaguen et al. [62] | 2 | 0.60-0.80 | 0.95-1.02 | 1.01-0.69 | 0.47-0.64 | |
Barea et al. [63] | 1-2 | 0.57-0.80 | 0.92-1.00 | ND2 | 0.50-0.60 | |
Nørgaard and Fernández [64] | 1-2 | 0.60-0.72 | 1.00 | 1.02 | 0.53; 0.62 | BCAA interaction |
Wiltafsky et al. [65] | 1-2 | 0.49-0.84 | 0.93-1.02 | 0.98-1.06 | 0.59-0.64 |
Source | Phase1 | Range of SID Ile: Lys ratio |
Range of SID Lys, % |
Range of SID Leu: Lys ratio |
Range of SID Val: Lys ratio |
Remarks |
Goodarzi et al. [48] | 1-2 | 0.29-0.60 | 1.29 | 0.82 | 0.39-0.75 | BCAA interaction |
Clizer et al. [11] | 3 | 0.55-0.75 | 0.73 | 1.61 | 0.78 | |
Goodarzi et al. [8] | 1-2 | 0.30-0.55 | 1.29 | 0.81 | 0.39-0.75 | BCAA interaction |
Habibi et al. [9] | 1-2 | 0.31-0.55 | 1.29 | 0.77 | 0.37-0.62 | BCAA interaction |
Kerkaert et al. [25] | 3 | 0.61-0.66 | 0.98 | 1.45 | 0.70 | |
Clark et al. [66] | 1 | 0.40-0.63 | 1.24-1.28 | 1.07-1.09 | 0.71 | |
Lazzeri et al. [67] | 2-3 | 0.45-0.73 | 1.06 | 0.99 | 0.65 | |
Clark et al. [68] | 1-2 | 0.40-0.63 | 1.24-1.28 | 1.07-1.09 | 0.71 | |
Htoo et al. [69] | 1-3 | 0.33-0.70 | 0.95 | 1.03-1.33 | 0.69-0.89 | |
Soumeh et al. [70] | 1-2 | 0.42-0.62 | 1.14 | ND2 | 0.70 | |
Gloaguen et al. [71] | 2 | 0.40-0.55 | 0.94-0.98 | 1.01-1.09 | ND2 | |
Nørgaard et al. [72] | 1-2 | 0.42-0.62 | 1.12 | ND2 | 0.70 | |
Waguespack et al. [60] | 2-3 | 0.52-0.61 | 0.83 | 1.30 | 0.73 | |
Barea et al. [73] | 2 | 0.46-0.65 | 1.00 | ND2 | ND2 | |
Nørgaard and Fernández [64] | 1-2 | 0.53-0.62 | 1.00 | 1.02 | 0.60-0.72 | BCAA interaction |
Wiltafsky et al. [74] | 1-2 | 0.36-0.72 | 0.92-1.02 | 1.08-1.62 | 0.68-1.02 |
Source | Phase1 | Range of SID SAA: Lys ratio |
Range of SID Met: Lys ratio |
Range of SID Lys, % |
Supplemental amino acid2 |
Remarks |
da Silva et al. [75] | 2-3 | 0.59-0.74 | ND3 | 0.96-1.07 | SAA | |
Yang et al. [76] | 2-3 | 0.48-0.62 | 0.20-0.34 | 1.08 | SAA+Met | |
Ho et al. [77] | 3 | 0.50-0.70 | 0.25-0.45 | 1.00 | SAA+Met | |
Remus et al. [78] | 3 | 0.37-0.57 | 0.21-0.39 | 1.15-1.30 | SAA+Met | |
Kahindi et al. [79] | 1 | 0.48-0.71 | 0.22-0.46 | 1.18 | SAA+Met | E. coli infection |
Zong et al. [10] | 1 | 0.39-0.71 | 0.20-0.52 | 1.35 | SAA+Met | |
Capozzalo et al. [80] | 1-2 | 0.45-0.78 | 0.21-0.53 | 1.10-1.20 | SAA+Met | E. coli infection |
Capozzalo et al. [81] | 1 | 0.55-0.66 | 0.28-0.39 | 1.25 | SAA | E. coli infection |
Kahindi et al. [82] | 1 | 0.52-0.68 | 0.24-0.40 | 1.18 | SAA+Met | Unclean condition |
Kaewtapee et al. [83] | 2-3 | 0.49-0.69 | ND3 | 1.05 | SAA | |
Zhang et al. [84] | 3 | 0.50-0.70 | 0.27-0.47 | 0.90 | SAA+Met | |
Chen et al. [85] | 1 | 0.39-0.48 | 0.20-0.29 | 1.20 | SAA+Met | |
Conde-Aguilera et al. [86] | 2-3 | 0.50-0.60 | 0.24-0.34 | 1.06-1.09 | SAA+Met | |
Conde-Aguilera et al. [87] | 2 | 0.38-0.60 | 0.17-0.40 | 1.16 | SAA+Met | |
Frantz et al. [88] | 3 | 0.47-0.63 | ND3 | 1.05 | SAA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated